Eosinophilic Fasciitis Triggered by Nivolumab: A Remarkable Efficacy of the mTOR Inhibitor Sirolimus.

• Authors: Erwan Le Tallec, Alain Lescoat, Alice Ballerie, Bérengère Cador, Hervé Lena, Charles Ricordel, Sène Damien, Céleste Lebbe, Patrick Jego, Nicolas Belhomme
• Journal: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer (J Thorac Oncol) Vol. 15 Issue 2 Pg. e29-e30 (02 2020) ISSN: 1556-1380 [Electronic] United States
• PMID: 32127188 (Publication Type: Letter)

Chemical References

• Nivolumab
• MTOR protein, human
• TOR Serine-Threonine Kinases
• Sirolimus

Topics

• Eosinophilia
• Fasciitis
• Humans
• Lung Neoplasms
• Nivolumab (adverse effects)
• Sirolimus (adverse effects)
• TOR Serine-Threonine Kinases